title: [Omega-3 fatty acids and cardiovascular diseases].
abstract: Most--but not all--epidemiological studies have demonstrated that omega-3 intake, either from nutrition or supplementation, reduces cardiovascular risk. A few intervention studies have shown a reduction of studden death in patients followed after a myocardial infarction. However EBM studies from the Cochrane Library do not confirm the real advantage of omega-3 in any group of subjects. Probably, the most interesting prescription of omega-3 supplementations would benefit to the patients after myocardial infarction, in addition to drugs that have proved their efficacy (aspirine, beta-blocker statin and ACE inhibitor).
authors.affiliation: Service d'Endocrinologie, C.H.U. de Charleroi.
authors.forename: J C
authors.initials: JC
authors.lastname: Daubresse
authors.forename: J
authors.initials: J
authors.lastname: Sternon
mesh_terms: D002318:Cardiovascular Diseases / Q000517:prevention & control*; D002986:Clinical Trials as Topic; D016021:Epidemiologic Studies; D015525:Fatty Acids, Omega-3 / Q000494:pharmacology* / Q000627:therapeutic use*; D006801:Humans; D009203:Myocardial Infarction / Q000150:complications
chemical_list: D015525:Fatty Acids, Omega-3